The simultaneous assessment of Cystatin C and NGAL levels we achieved allows for rapid and accurate diagnosis of AKI within a large temporal window after the injury and with a matching performance compared with a state of the art ELISA kit. This evidence concerns the gene LCN2 and acute kidney injury.